Document is current
Any future updates will be listed below
-
Authors
Holm, Karin https://orcid.org/0000-0002-8289-5949
Lundgren, Maria N.
Kjeldsen-Kragh, Jens
Ljungquist, Oskar
Böttiger, Blenda
Wikén, Christian
Öberg, Jonas
Fernström, Nils
Rosendal, Ebba
Överby, Anna K.
Wigren Byström, Julia
Forsell, Mattias
Landin-Olsson, Mona
Rasmussen, Magnus
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04600440 at ClinicalTrials.govDocuments that mention this clinical trial
Convalescence plasma treatment of COVID-19: results from a prematurely terminated randomized controlled open-label study in Southern Sweden
https://doi.org/10.1186/s13104-021-05847-7
-
Funding
Funding for this research was provided by:
region skåne
- License Information
-
More Information
Article History
Received: 2 July 2021
Accepted: 12 November 2021
First Online: 4 December 2021
Declarations
:
: The Swedish Ethical Review Authority approved the study (Reference Number #2020-01744, 2020-03595). Written informed consent was required from donors and patients on inclusion.
: Not applicable.
: The authors declare no competing interests.
